Tom Gayner Thermo Fisher Scientific Inc. Transaction History

Markel Corp

$10.3 Billion
Q3 2024

A detailed history of Tom Gayner (Markel Corp) transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Markel Corp holds 35,400 shares of TMO stock, worth $18.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

35,400

Previous 29,400 20.41%

Holding current value

$18.2 Million

Previous $16.3 Million 34.67%

% of portfolio

0.21%

Previous 0.17%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$531.86 - $624.21 $3.19 Million - $3.75 Million	6,000 Added 20.41%	35,400 $21.9 Million
Q2 2024 Aug 02, 2024	BUY	$541.52 - $599.02 $2.55 Million - $2.82 Million	4,700 Added 19.03%	29,400 $16.3 Million
Q1 2024 May 03, 2024	BUY	$528.82 - $599.43 $2.7 Million - $3.06 Million	5,100 Added 26.02%	24,700 $14.4 Million
Q4 2023 Feb 02, 2024	BUY	$431.41 - $532.94 $2.59 Million - $3.2 Million	6,000 Added 44.12%	19,600 $10.4 Million
Q3 2023 Nov 03, 2023	BUY	$498.29 - $574.41 $2.69 Million - $3.1 Million	5,400 Added 65.85%	13,600 $6.88 Million
Q4 2022 Feb 03, 2023	BUY	$484.71 - $571.37 $193,884 - $228,548	400 Added 5.13%	8,200 $4.52 Million
Q3 2022 Nov 04, 2022	BUY	$507.19 - $604.49 $659,347 - $785,837	1,300 Added 20.0%	7,800 $3.96 Million
Q2 2022 Aug 05, 2022	BUY	$500.9 - $612.21 $2.28 Million - $2.79 Million	4,550 Added 233.33%	6,500 $3.53 Million
Q1 2022 Apr 29, 2022	BUY	$524.0 - $644.92 $864,600 - $1.06 Million	1,650 Added 550.0%	1,950 $1.15 Million
Q4 2021 Feb 04, 2022	BUY	$569.0 - $667.24 $170,700 - $200,172	300 New	300 $200,000

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track Tom Gayner's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Markel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Markel Corp and Tom Gayner with notifications on news.

Account